Bio-Techne Scientist Presented with the CASSS CE Pharm Award

News provided by

Oct 02, 2018, 09:15 ET

MINNEAPOLIS, Oct. 2, 2018 /PRNewswire/ -- Bio-Techne is proud to announce that one of its Principal Scientists, Jiaqi Wu, Ph.D., was presented with the CE Pharm Award at this year's CE Pharm meeting, September 9-12, 2018, for his contributions to the capillary electrophoresis (CE) field.

Jiaqi Wu, Ph.D., Principal Scientist at Bio-Techne, received the CE Pharm Award at the CE Pharm 2018 meeting held September 9-12, 2018, in San Francisco, CA, USA.

Each year since 2006, the CASSS organization has identified an individual that has made continual and significant contributions to advance the CE field and its use in the analysis of biotechnology and pharmaceutical products. Past recipients of this prestigious award include Meg Ruesch, Ph.D., Vice President of ARD at Pfizer and Wassim Nashabeh, Ph.D., Vice President of Regulatory Policy and International Operations at Roche. This year, the CASSS organization recognized Dr. Wu's ground-breaking role in developing iCE^™ technology. This technology has enabled researchers in the biologic therapeutics development field to get results faster and has allowed companies to bring their innovative products to market quicker for improving patient care and longevity. Dr. Wu, who is viewed as a leader in this field by his peers, also holds four patents, has published almost 50 papers in peer-reviewed journals, and acts as a reviewer for several journals including Analytical Chemistry, Analytica Chimica Acta, and Journal of Chromatography. In addition to these achievements, the CASSS organization also recognized Dr. Wu's tireless commitment to supporting this technology and the CE field globally.

Dave Eansor, President of Bio-Techne's Protein Sciences Segment, commented, "I would like to congratulate Jiaqi on being given this esteemed award and for being the first scientist from a tools company to receive this distinguished honor. Jiaqi is a pioneer in the imaged capillary IEF field and has been instrumental in developing our ProteinSimple-branded iCE^™ instruments. We are honored that he has chosen to spend the past 22 years of his career with us."

Please visit www.proteinsimple.com to view the ProteinSimple-branded instruments that utilize the iCE^™ technology.

About Bio-Techne Corporation (NASDAQ: TECH)

Contact: Dave Eansor, President, Protein Sciences Segment, 612-379-2956

SOURCE Bio-Techne Corporation